Symmetry Medical's short interest sales decreased 41.3 percent during the month of August, according to a WKRB News & Analysis report.
Here are five things to know about the company's shares:
• There were 735,172 short interest shares as of August 15, which decreased from around 1.2 million shares on July 31.
• The daily trading volume is 375,115 shares with a days-to-cover ratio at two days.
• Around 2 percent of the shares are short sold.
• Zacks upgraded Symmetry shares from "neutral" to "outperform" on Aug. 21.
• Zacks has an $11 price target on the stock.
The company reported earnings on Aug. 4 with $101 million in second quarter revenue. Revenue was up 2.3 percent. The company divested OEM Solutions earlier this year and the move is expected to improve liquidity and enhance growth.